Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE34.1600
- TODAY'S CHANGE (%)-1.1700 (-3.3116%)
- Bid / Lots33.1800/ 1
- Ask / Lots35.1600/ 1
- Open / Previous Close35.4100 / 35.3300
- Day Range
- 52 Week Range
- Volume493,066
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 2027 | 35.865 |
| 09:34 ET | 100 | 35.415 |
| 09:39 ET | 433 | 35.405 |
| 09:41 ET | 1400 | 35.345 |
| 09:43 ET | 702 | 35.27 |
| 09:45 ET | 10597 | 35.1 |
| 09:48 ET | 1900 | 35.1323 |
| 09:50 ET | 1000 | 35.145 |
| 09:54 ET | 300 | 34.99 |
| 09:56 ET | 21628 | 34.86 |
| 09:57 ET | 1568 | 34.86 |
| 09:59 ET | 300 | 34.81 |
| 10:01 ET | 1000 | 34.86 |
| 10:08 ET | 100 | 34.68 |
| 10:10 ET | 766 | 34.775 |
| 10:12 ET | 200 | 34.76 |
| 10:14 ET | 300 | 34.66 |
| 10:15 ET | 500 | 34.77 |
| 10:19 ET | 100 | 34.59 |
| 10:21 ET | 200 | 34.58 |
| 10:24 ET | 200 | 34.45 |
| 10:26 ET | 200 | 34.44 |
| 10:28 ET | 999 | 34.405 |
| 10:30 ET | 400 | 34.343 |
| 10:32 ET | 900 | 34.45 |
| 10:35 ET | 200 | 34.44 |
| 10:37 ET | 1998 | 34.48 |
| 10:39 ET | 1300 | 34.45 |
| 10:42 ET | 500 | 34.435 |
| 10:44 ET | 900 | 34.525 |
| 10:46 ET | 400 | 34.585 |
| 10:48 ET | 1700 | 34.595 |
| 10:50 ET | 300 | 34.69 |
| 10:51 ET | 1600 | 34.73 |
| 10:53 ET | 2000 | 34.77 |
| 10:55 ET | 100 | 34.835 |
| 10:57 ET | 800 | 34.775 |
| 11:00 ET | 200 | 34.73 |
| 11:02 ET | 100 | 34.7 |
| 11:04 ET | 1207 | 34.715 |
| 11:06 ET | 300 | 34.715 |
| 11:08 ET | 100 | 34.7 |
| 11:09 ET | 500 | 34.72 |
| 11:11 ET | 300 | 34.72 |
| 11:13 ET | 726 | 34.71 |
| 11:15 ET | 200 | 34.705 |
| 11:18 ET | 428 | 34.6825 |
| 11:20 ET | 617 | 34.7 |
| 11:22 ET | 100 | 34.7 |
| 11:24 ET | 5681 | 34.735 |
| 11:27 ET | 400 | 34.7 |
| 11:29 ET | 3905 | 34.645 |
| 11:31 ET | 1058 | 34.59 |
| 11:33 ET | 2140 | 34.43 |
| 11:36 ET | 1000 | 34.42 |
| 11:38 ET | 1227 | 34.435 |
| 11:40 ET | 400 | 34.48 |
| 11:42 ET | 200 | 34.44 |
| 11:44 ET | 1272 | 34.43 |
| 11:45 ET | 1857 | 34.435 |
| 11:49 ET | 100 | 34.45 |
| 11:51 ET | 300 | 34.5 |
| 11:54 ET | 543 | 34.45 |
| 11:56 ET | 3801 | 34.55 |
| 11:58 ET | 500 | 34.57 |
| 12:00 ET | 1640 | 34.52 |
| 12:02 ET | 100 | 34.495 |
| 12:03 ET | 100 | 34.5 |
| 12:05 ET | 100 | 34.5 |
| 12:07 ET | 300 | 34.45 |
| 12:09 ET | 100 | 34.45 |
| 12:12 ET | 1000 | 34.505 |
| 12:14 ET | 2500 | 34.545 |
| 12:16 ET | 4546 | 34.51 |
| 12:18 ET | 300 | 34.51 |
| 12:20 ET | 100 | 34.45 |
| 12:21 ET | 15656 | 34.59 |
| 12:25 ET | 600 | 34.55 |
| 12:27 ET | 1800 | 34.59 |
| 12:30 ET | 800 | 34.63 |
| 12:32 ET | 100 | 34.61 |
| 12:36 ET | 200 | 34.6 |
| 12:39 ET | 200 | 34.54 |
| 12:41 ET | 1600 | 34.6425 |
| 12:43 ET | 100 | 34.645 |
| 12:45 ET | 1000 | 34.67 |
| 12:48 ET | 100 | 34.63 |
| 12:50 ET | 100 | 34.52 |
| 12:52 ET | 1397 | 34.49 |
| 12:54 ET | 16234 | 34.3 |
| 12:57 ET | 11800 | 34.34 |
| 12:59 ET | 1500 | 34.4 |
| 01:01 ET | 1391 | 34.38 |
| 01:03 ET | 100 | 34.35 |
| 01:06 ET | 2000 | 34.35 |
| 01:08 ET | 2983 | 34.32 |
| 01:10 ET | 1200 | 34.45 |
| 01:12 ET | 300 | 34.475 |
| 01:14 ET | 600 | 34.5 |
| 01:15 ET | 200 | 34.51 |
| 01:19 ET | 4495 | 34.62 |
| 01:21 ET | 1901 | 34.6 |
| 01:24 ET | 1700 | 34.54 |
| 01:26 ET | 1194 | 34.51 |
| 01:28 ET | 700 | 34.48 |
| 01:30 ET | 700 | 34.535 |
| 01:32 ET | 1198 | 34.58 |
| 01:33 ET | 700 | 34.595 |
| 01:35 ET | 400 | 34.56 |
| 01:37 ET | 300 | 34.555 |
| 01:39 ET | 400 | 34.58 |
| 01:42 ET | 500 | 34.565 |
| 01:44 ET | 300 | 34.54 |
| 01:46 ET | 300 | 34.54 |
| 01:48 ET | 100 | 34.52 |
| 01:50 ET | 2401 | 34.55 |
| 01:51 ET | 300 | 34.51 |
| 01:53 ET | 400 | 34.49 |
| 01:55 ET | 2281 | 34.55 |
| 01:57 ET | 900 | 34.57 |
| 02:00 ET | 1500 | 34.55 |
| 02:02 ET | 1795 | 34.61 |
| 02:04 ET | 4359 | 34.71 |
| 02:06 ET | 2000 | 34.805 |
| 02:08 ET | 1100 | 34.77 |
| 02:09 ET | 1100 | 34.795 |
| 02:11 ET | 800 | 34.81 |
| 02:13 ET | 1883 | 34.72 |
| 02:15 ET | 1908 | 34.67 |
| 02:18 ET | 1108 | 34.65 |
| 02:20 ET | 2036 | 34.63 |
| 02:22 ET | 100 | 34.64 |
| 02:24 ET | 963 | 34.58 |
| 02:26 ET | 200 | 34.57 |
| 02:27 ET | 300 | 34.56 |
| 02:29 ET | 600 | 34.5 |
| 02:31 ET | 514 | 34.5 |
| 02:33 ET | 800 | 34.465 |
| 02:36 ET | 1502 | 34.53 |
| 02:38 ET | 1200 | 34.5 |
| 02:40 ET | 400 | 34.445 |
| 02:42 ET | 200 | 34.445 |
| 02:44 ET | 900 | 34.46 |
| 02:45 ET | 500 | 34.46 |
| 02:47 ET | 1901 | 34.5 |
| 02:49 ET | 3803 | 34.56 |
| 02:51 ET | 309 | 34.56 |
| 02:54 ET | 1141 | 34.54 |
| 02:56 ET | 100 | 34.51 |
| 02:58 ET | 200 | 34.54 |
| 03:00 ET | 1300 | 34.6 |
| 03:02 ET | 2803 | 34.54 |
| 03:03 ET | 1734 | 34.48 |
| 03:05 ET | 3038 | 34.46 |
| 03:07 ET | 600 | 34.5 |
| 03:09 ET | 1690 | 34.48 |
| 03:12 ET | 500 | 34.42 |
| 03:14 ET | 600 | 34.45 |
| 03:16 ET | 1400 | 34.44 |
| 03:18 ET | 400 | 34.41 |
| 03:20 ET | 700 | 34.4 |
| 03:21 ET | 3200 | 34.4 |
| 03:23 ET | 600 | 34.35 |
| 03:25 ET | 1710 | 34.355 |
| 03:27 ET | 400 | 34.35 |
| 03:30 ET | 1200 | 34.31 |
| 03:32 ET | 1000 | 34.29 |
| 03:34 ET | 600 | 34.25 |
| 03:36 ET | 1400 | 34.24 |
| 03:38 ET | 100 | 34.2 |
| 03:39 ET | 2300 | 34.18 |
| 03:41 ET | 1900 | 34.15 |
| 03:43 ET | 2300 | 34.11 |
| 03:45 ET | 2700 | 34.13 |
| 03:48 ET | 3900 | 34.21 |
| 03:50 ET | 2400 | 34.21 |
| 03:52 ET | 3516 | 34.3 |
| 03:54 ET | 6012 | 34.325 |
| 03:56 ET | 9815 | 34.2 |
| 03:57 ET | 5101 | 34.15 |
| 03:59 ET | 60920 | 34.16 |
Sep 22, 2023
DJ Xenon Pharmaceuticals Price Target Maintained With a $51.00/Share by RBC Capital, from 11:04AM ET on Friday Sep 22, 2023 by Dow Jones
11:04AM ET on Friday Sep 22, 2023 by Dow Jones
Sep 14, 2023
Xenon Pharmaceuticals to Present at TD Cowen's 3rd Annual Novel Mechanisms in Neuropsychiatry Summit, from 4:01PM ET on Thursday Sep 14, 2023 by Dow Jones
4:01PM ET on Thursday Sep 14, 2023 by Dow JonesDJ Xenon Pharmaceuticals Inc. on Track for Longest Losing Streak Since April 2019 -- Data Talk, from 1:30PM ET on Thursday Sep 14, 2023 by Dow Jones
1:30PM ET on Thursday Sep 14, 2023 by Dow Jones
Sep 12, 2023
Sep 4, 2023
Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress, from 8:30AM ET on Monday Sep 04, 2023 by Dow Jones
8:30AM ET on Monday Sep 04, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.3B | -13.7x | --- |
Ventyx Biosciences Inc | 2.1B | -12.4x | --- |
Neumora Therapeutics Inc | 2.0B | -16.3x | --- |
Crinetics Pharmaceuticals Inc | 1.9B | -8.7x | --- |
Nuvalent Inc | 2.7B | -24.8x | --- |
Rocket Pharmaceuticals Inc | 1.9B | -6.2x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
|---|---|
Revenue (TTM) | $132.0K |
Shares Outstanding | 64.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $-2.49 |
Book Value | $11.53 |
P/E Ratio | -13.7x |
Price/Sales (TTM) | 17,168.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -141,010.60% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
